I’m going to repeat my previous sentiments sorry for this.
I believe we should put the value derived from Bisantrene through the excellent research conducted before the bottom line.
Let me take you back in time for a story. Imagine it is 1980 and you are in the infancy of oncology and have developed
Bisantrene as a drug fit to fight many types of cancers.
All of a sudden it was forgotten due to M&A and mishandling.
However, what was not forgotten was the hours of research, drug discovery, toxicology and the countless lives it saved. We are currently at the fore front of FTO. Who knows what the future holds? No one could of predicted the come back of Bisantrene but the contributions the previous owners made will never be forgotten because it ended up in scientific journals and databases for an opportunist to come in and not only reap the fruits of the past labour but to add a flame of hope for new area’s in the field of oncology.
Over and out.
I’m going to repeat my previous sentiments sorry for this.I...
-
- There are more pages in this discussion • 17,028 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.84 |
Change
-0.025(1.34%) |
Mkt cap ! $313.3M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.91 | $1.81 | $257.6K | 138.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 26825 | $1.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.90 | 759 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |